Np mrd loader

Record Information
Version1.0
Created at2021-06-21 00:38:10 UTC
Updated at2021-06-30 00:18:40 UTC
NP-MRD IDNP0043148
Secondary Accession NumbersNone
Natural Product Identification
Common Namefluevirosine B
Provided ByJEOL DatabaseJEOL Logo
Description(1R,2R,8R,9S)-9-[(1S,7S,8S,13R)-3-oxo-7-[(1S,8S,13R)-3-oxo-2-oxa-9-azatetracyclo[6.5.1.0¹,⁵.0⁹,¹³]Tetradeca-4,6-dien-6-yl]-2-oxa-9-azatetracyclo[6.5.1.0¹,⁵.0⁹,¹³]Tetradec-4-en-4-yl]-14-oxa-7-azatetracyclo[6.6.1.0¹,¹¹.0²,⁷]Pentadec-11-en-13-one belongs to the class of organic compounds known as indolizidines. These are polycyclic compounds containing an indolizidine, which is a bicyclic heterocycle containing a saturated six-member ring fused to a saturated five-member ring, one of the bridging atoms being nitrogen. fluevirosine B is found in Flueggea virosa. It was first documented in 2002 (PMID: 29437326). Based on a literature review a significant number of articles have been published on (1R,2R,8R,9S)-9-[(1S,7S,8S,13R)-3-oxo-7-[(1S,8S,13R)-3-oxo-2-oxa-9-azatetracyclo[6.5.1.0¹,⁵.0⁹,¹³]Tetradeca-4,6-dien-6-yl]-2-oxa-9-azatetracyclo[6.5.1.0¹,⁵.0⁹,¹³]Tetradec-4-en-4-yl]-14-oxa-7-azatetracyclo[6.6.1.0¹,¹¹.0²,⁷]Pentadec-11-en-13-one (PMID: 27466641) (PMID: 27253005) (PMID: 26389468) (PMID: 26389426).
Structure
Thumb
SynonymsNot Available
Chemical FormulaC37H41N3O6
Average Mass623.7500 Da
Monoisotopic Mass623.29954 Da
IUPAC Name(1R,2R,8R,9S)-9-[(1S,7S,8S,13R)-3-oxo-7-[(1S,8S,13R)-3-oxo-2-oxa-9-azatetracyclo[6.5.1.0^{1,5}.0^{9,13}]tetradeca-4,6-dien-6-yl]-2-oxa-9-azatetracyclo[6.5.1.0^{1,5}.0^{9,13}]tetradec-4-en-4-yl]-14-oxa-7-azatetracyclo[6.6.1.0^{1,11}.0^{2,7}]pentadec-11-en-13-one
Traditional Name(1R,2R,8R,9S)-9-[(1S,7S,8S,13R)-3-oxo-7-[(1S,8S,13R)-3-oxo-2-oxa-9-azatetracyclo[6.5.1.0^{1,5}.0^{9,13}]tetradeca-4,6-dien-6-yl]-2-oxa-9-azatetracyclo[6.5.1.0^{1,5}.0^{9,13}]tetradec-4-en-4-yl]-14-oxa-7-azatetracyclo[6.6.1.0^{1,11}.0^{2,7}]pentadec-11-en-13-one
CAS Registry NumberNot Available
SMILES
[H]C1=C2C(=C([H])[C@@]3([H])N4C([H])([H])C([H])([H])C([H])([H])[C@]4([H])[C@]2(OC1=O)C3([H])[H])[C@]1([H])C([H])([H])C2=C(C(=O)O[C@@]22C([H])([H])[C@]1([H])N1C([H])([H])C([H])([H])C([H])([H])[C@]21[H])[C@]1([H])C([H])([H])C2=C([H])C(=O)O[C@]22C([H])([H])[C@@]1([H])N1C([H])([H])C([H])([H])C([H])([H])C([H])([H])[C@]21[H]
InChI Identifier
InChI=1S/C37H41N3O6/c41-31-12-19-11-23(27-17-35(19,44-31)28-5-1-2-8-39(27)28)33-25-14-22(26-18-37(25,46-34(33)43)30-7-4-10-40(26)30)21-13-20-16-36(24(21)15-32(42)45-36)29-6-3-9-38(20)29/h12-13,15,20,22-23,26-30H,1-11,14,16-18H2/t20-,22+,23-,26+,27-,28-,29-,30-,35-,36+,37+/m1/s1
InChI KeyHYWYNBKAWUIHFN-NOLXPYPPSA-N
Experimental Spectra
Spectrum TypeDescriptionDepositor EmailDepositor OrganizationDepositorDeposition DateView
1D NMR13C NMR Spectrum (1D, 600 MHz, CDCl3, simulated)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 600 MHz, CDCl3, simulated)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 100 MHz, CDCl3, simulated)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 100 MHz, CDCl3, simulated)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 200 MHz, CDCl3, simulated)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 200 MHz, CDCl3, simulated)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 300 MHz, CDCl3, simulated)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 300 MHz, CDCl3, simulated)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 400 MHz, CDCl3, simulated)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 400 MHz, CDCl3, simulated)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 500 MHz, CDCl3, simulated)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 500 MHz, CDCl3, simulated)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 700 MHz, CDCl3, simulated)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 700 MHz, CDCl3, simulated)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 800 MHz, CDCl3, simulated)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 800 MHz, CDCl3, simulated)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 900 MHz, CDCl3, simulated)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 900 MHz, CDCl3, simulated)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR13C NMR Spectrum (1D, 1000 MHz, CDCl3, simulated)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
1D NMR1H NMR Spectrum (1D, 1000 MHz, CDCl3, simulated)Wishart LabWishart LabDavid Wishart2021-06-20View Spectrum
Predicted Spectra
Not Available
Chemical Shift Submissions
Not Available
Species
Species of Origin
Species NameSourceReference
Flueggea virosaJEOL database
    • Zhang, H., et al, Org. Lett.,15 120 (2013)
Chemical Taxonomy
Description Belongs to the class of organic compounds known as indolizidines. These are polycyclic compounds containing an indolizidine, which is a bicyclic heterocycle containing a saturated six-member ring fused to a saturated five-member ring, one of the bridging atoms being nitrogen.
KingdomOrganic compounds
Super ClassOrganoheterocyclic compounds
ClassIndolizidines
Sub ClassNot Available
Direct ParentIndolizidines
Alternative Parents
Substituents
  • Indolizidine
  • Tricarboxylic acid or derivatives
  • Pyrrolizidine
  • Azepane
  • Azepine
  • 2-furanone
  • Piperidine
  • N-alkylpyrrolidine
  • Dihydrofuran
  • Pyrrolidine
  • Alpha,beta-unsaturated carboxylic ester
  • Enoate ester
  • Amino acid or derivatives
  • Tertiary aliphatic amine
  • Tertiary amine
  • Lactone
  • Carboxylic acid ester
  • Azacycle
  • Oxacycle
  • Carboxylic acid derivative
  • Organic nitrogen compound
  • Hydrocarbon derivative
  • Carbonyl group
  • Organic oxide
  • Organic oxygen compound
  • Organonitrogen compound
  • Organooxygen compound
  • Amine
  • Aliphatic heteropolycyclic compound
Molecular FrameworkAliphatic heteropolycyclic compounds
External DescriptorsNot Available
Physical Properties
StateNot Available
Experimental Properties
PropertyValueReference
Melting PointNot AvailableNot Available
Boiling PointNot AvailableNot Available
Water SolubilityNot AvailableNot Available
LogPNot AvailableNot Available
Predicted Properties
PropertyValueSource
logP2.67ALOGPS
logP2.4ChemAxon
logS-3.6ALOGPS
pKa (Strongest Acidic)14.68ChemAxon
pKa (Strongest Basic)10.15ChemAxon
Physiological Charge3ChemAxon
Hydrogen Acceptor Count6ChemAxon
Hydrogen Donor Count0ChemAxon
Polar Surface Area88.62 ŲChemAxon
Rotatable Bond Count2ChemAxon
Refractivity168.4 m³·mol⁻¹ChemAxon
Polarizability67.84 ųChemAxon
Number of Rings12ChemAxon
BioavailabilityYesChemAxon
Rule of FiveNoChemAxon
Ghose FilterNoChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleNoChemAxon
HMDB IDNot Available
DrugBank IDNot Available
Phenol Explorer Compound IDNot Available
FoodDB IDNot Available
KNApSAcK IDNot Available
Chemspider IDNot Available
KEGG Compound IDNot Available
BioCyc IDNot Available
BiGG IDNot Available
Wikipedia LinkNot Available
METLIN IDNot Available
PubChem Compound71544999
PDB IDNot Available
ChEBI IDNot Available
Good Scents IDNot Available
References
General References
  1. Authors unspecified: Childhood Cancer Genomics (PDQ(R)): Health Professional Version. 2002. [PubMed:27466641 ]
  2. Authors unspecified: Thyroid Cancer Screening (PDQ(R)): Patient Version. 2002. [PubMed:29437326 ]
  3. Authors unspecified: Childhood Vascular Tumors Treatment (PDQ(R)): Patient Version. 2002. [PubMed:27253005 ]
  4. Authors unspecified: Stomach (Gastric) Cancer Prevention (PDQ(R)): Patient Version. 2002. [PubMed:26389468 ]
  5. Authors unspecified: Childhood Central Nervous System Atypical Teratoid/Rhabdoid Tumor Treatment (PDQ(R)): Health Professional Version. 2002. [PubMed:26389426 ]
  6. Zhang, H., et al. (2013). Zhang, H., et al, Org. Lett.,15 120 (2013). Org. Lett..